These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 26324028)
1. Benefits of Prophylactic Proton Pump Inhibitors after Roux-en-Y Gastric Bypass Surgery: A Retrospective Study. Plaeke P; Ruppert M; Hubens G Acta Chir Belg; 2015; 115(4):273-8. PubMed ID: 26324028 [TBL] [Abstract][Full Text] [Related]
2. The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study. Coblijn UK; Lagarde SM; de Castro SM; Kuiken SD; van Tets WF; van Wagensveld BA Surg Obes Relat Dis; 2016 Feb; 12(2):246-52. PubMed ID: 26381875 [TBL] [Abstract][Full Text] [Related]
3. Opened Proton Pump Inhibitor Capsules Reduce Time to Healing Compared With Intact Capsules for Marginal Ulceration Following Roux-en-Y Gastric Bypass. Schulman AR; Chan WW; Devery A; Ryan MB; Thompson CC Clin Gastroenterol Hepatol; 2017 Apr; 15(4):494-500.e1. PubMed ID: 27773764 [TBL] [Abstract][Full Text] [Related]
4. Early marginal ulcer following Roux-en-Y gastric bypass under proton pump inhibitor treatment: prospective multicentric study. Garrido AB; Rossi M; Lima SE; Brenner AS; Gomes CA Arq Gastroenterol; 2010; 47(2):130-4. PubMed ID: 20721455 [TBL] [Abstract][Full Text] [Related]
5. Management of anastomotic ulcers after Roux-en-Y gastric bypass: results of an international survey. Steinemann DC; Bueter M; Schiesser M; Amygdalos I; Clavien PA; Nocito A Obes Surg; 2014 May; 24(5):741-6. PubMed ID: 24347350 [TBL] [Abstract][Full Text] [Related]
6. Two important criteria for reducing the risk of postoperative ulcers at the gastrojejunostomy site after gastric bypass: patient compliance and type of gastric bypass. Scheffel O; Daskalakis M; Weiner RA Obes Facts; 2011; 4 Suppl 1(Suppl 1):39-41. PubMed ID: 22027289 [TBL] [Abstract][Full Text] [Related]
7. A comparison of 30-day versus 90-day proton pump inhibitor therapy in prevention of marginal ulcers after laparoscopic Roux-en-Y gastric bypass. Kang X; Zurita-Macias L; Hong D; Cadeddu M; Anvari M; Gmora S Surg Obes Relat Dis; 2016 Jun; 12(5):1003-1007. PubMed ID: 26948448 [TBL] [Abstract][Full Text] [Related]
9. Management of gastrogastric fistulas after divided Roux-en-Y gastric bypass surgery for morbid obesity: analysis of 1,292 consecutive patients and review of literature. Carrodeguas L; Szomstein S; Soto F; Whipple O; Simpfendorfer C; Gonzalvo JP; Villares A; Zundel N; Rosenthal R Surg Obes Relat Dis; 2005; 1(5):467-74. PubMed ID: 16925272 [TBL] [Abstract][Full Text] [Related]
10. Endoscopic suture removal at gastrojejunal anastomosis after Roux-en-Y gastric bypass to prevent marginal ulceration. Frezza EE; Herbert H; Ford R; Wachtel MS Surg Obes Relat Dis; 2007; 3(6):619-22. PubMed ID: 18023815 [TBL] [Abstract][Full Text] [Related]
11. Management and treatment outcomes of marginal ulcers after Roux-en-Y gastric bypass at a single high volume bariatric center. Moon RC; Teixeira AF; Goldbach M; Jawad MA Surg Obes Relat Dis; 2014; 10(2):229-34. PubMed ID: 24462313 [TBL] [Abstract][Full Text] [Related]
12. Can a short course of prophylactic low-dose proton pump inhibitor therapy prevent stomal ulceration after laparoscopic Roux-en-Y gastric bypass? D'Hondt MA; Pottel H; Devriendt D; Van Rooy F; Vansteenkiste F Obes Surg; 2010 May; 20(5):595-9. PubMed ID: 20058097 [TBL] [Abstract][Full Text] [Related]
13. Revision with Totally Hand-Sewn Gastrojejunostomy and Vagotomy for Refractory Marginal Ulcer after Laparoscopic Roux-en-Y Gastric Bypass. Chang PC; Huang CK; Rajan M; Hsin MC Obes Surg; 2016 May; 26(5):1150. PubMed ID: 27000883 [TBL] [Abstract][Full Text] [Related]
14. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Rasmussen JJ; Fuller W; Ali MR Surg Endosc; 2007 Jul; 21(7):1090-4. PubMed ID: 17514403 [TBL] [Abstract][Full Text] [Related]
15. Acid-related complications after laparoscopic Roux-en-Y gastric bypass: risk factors and impact of proton pump inhibitors. Wennerlund J; Gunnarsson U; Strigård K; Sundbom M Surg Obes Relat Dis; 2020 May; 16(5):620-625. PubMed ID: 32107170 [TBL] [Abstract][Full Text] [Related]
16. Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Sacks BC; Mattar SG; Qureshi FG; Eid GM; Collins JL; Barinas-Mitchell EJ; Schauer PR; Ramanathan RC Surg Obes Relat Dis; 2006; 2(1):11-6. PubMed ID: 16925306 [TBL] [Abstract][Full Text] [Related]
17. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Azagury DE; Abu Dayyeh BK; Greenwalt IT; Thompson CC Endoscopy; 2011 Nov; 43(11):950-4. PubMed ID: 21997722 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic proton pump inhibitors in femoral neck fracture patients - A life - and cost-saving intervention. Singh R; Trickett R; Meyer C; Lewthwaite S; Ford D Ann R Coll Surg Engl; 2016 Jul; 98(6):371-5. PubMed ID: 27055405 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic PPI help reduce marginal ulcers after gastric bypass surgery: a systematic review and meta-analysis of cohort studies. Ying VW; Kim SH; Khan KJ; Farrokhyar F; D'Souza J; Gmora S; Anvari M; Hong D Surg Endosc; 2015 May; 29(5):1018-23. PubMed ID: 25159641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]